The consideration of a patient's treatment preference may be essential in determining how a patient will respond to a particular treatment. While traditional clinical trials are unable to capture these effects, the two-stage randomized preference design provides an important tool for researchers seeking to understand the role of patient preferences. In addition to the treatment effect, these designs seek to estimate the role of preferences through testing of selection and preference effects. The R package preference facilitates the use of two-stage clinical trials by providing the necessary tools to design and analyze these studies. To aid in the design, functions are provided to estimate the required sample size and to estimate the study p...
Objectives: To investigate stakeholder perspectives on how patient preference studies (PPS) should b...
Objectives: To investigate stakeholder perspectives on how patient preference studies (PPS) should b...
Objectives: To investigate stakeholder perspectives on how patient preference studies (PPS) should b...
Objective: To systematically review fully randomised patient preference trials and to explore the im...
OBJECTIVE: Randomised controlled trials (RCT) are the gold standard to provide unbiased data. Howeve...
Objectives: To develop a conceptual framework of preferences for interventions in the context of ran...
It is well established that random assignment between experimental treatment and control arms is the...
© 2019, © 2019 American Statistical Association. Social and medical scientists are often concerned t...
Social and medical scientists are often concerned that the external validity of experimental results...
© 2019, © 2019 American Statistical Association. Social and medical scientists are often concerned t...
BACKGROUND: Clinical trial design requires value judgements and understanding patient preferences ma...
BACKGROUND: Clinical trial design requires value judgements and understanding patient preferences ma...
BACKGROUND: Clinical trial design requires value judgements and understanding patient preferences ma...
Background: Preference assessments of patients with rheumatoid arthritis can support clinical therap...
Preference studies are becoming increasingly important within the medical product decision-making co...
Objectives: To investigate stakeholder perspectives on how patient preference studies (PPS) should b...
Objectives: To investigate stakeholder perspectives on how patient preference studies (PPS) should b...
Objectives: To investigate stakeholder perspectives on how patient preference studies (PPS) should b...
Objective: To systematically review fully randomised patient preference trials and to explore the im...
OBJECTIVE: Randomised controlled trials (RCT) are the gold standard to provide unbiased data. Howeve...
Objectives: To develop a conceptual framework of preferences for interventions in the context of ran...
It is well established that random assignment between experimental treatment and control arms is the...
© 2019, © 2019 American Statistical Association. Social and medical scientists are often concerned t...
Social and medical scientists are often concerned that the external validity of experimental results...
© 2019, © 2019 American Statistical Association. Social and medical scientists are often concerned t...
BACKGROUND: Clinical trial design requires value judgements and understanding patient preferences ma...
BACKGROUND: Clinical trial design requires value judgements and understanding patient preferences ma...
BACKGROUND: Clinical trial design requires value judgements and understanding patient preferences ma...
Background: Preference assessments of patients with rheumatoid arthritis can support clinical therap...
Preference studies are becoming increasingly important within the medical product decision-making co...
Objectives: To investigate stakeholder perspectives on how patient preference studies (PPS) should b...
Objectives: To investigate stakeholder perspectives on how patient preference studies (PPS) should b...
Objectives: To investigate stakeholder perspectives on how patient preference studies (PPS) should b...